Anpario PLC (AIM: ANP) reported higher sales and profit for the first half of 2026, though management warned that conflict in the Middle East is weighing on Demand in Asia and is expected to keep doing so through the rest of the year. The interim results were published on 9 September 2026, and they remain the most recent full financial update found in this search.

What Anpario does

Anpario describes itself as an independent manufacturer of natural, sustainable feed additives for animal health, nutrition and biosecurity. Its products are sold to livestock producers and feed companies, so its fortunes track farm economics, disease pressure and the willingness of producers to invest in feed efficiency. The company is listed on AIM and is a constituent of the FTSE AIM All Share Index.

The September interim figures

For the six months to 30 June 2026, sales rose 7% to £24.3m, compared with £22.7m a year earlier. Profit before tax increased 11% to £3.8m from £3.4m, while adjusted EBITDA climbed 22% to £5.0m from £4.1m. Diluted adjusted Earnings Per Share rose 30% to 20.77p, against 16.01p in the first half of 2025.

The faster growth in earnings than in sales suggests an improvement in margins, although the sources reviewed do not break down the drivers in detail. Anpario also said Bio-Vet will be rebranded as Anpario from October.

Dividend, cash and buybacks

The board lifted the interim Dividend 6% to 3.8p per share from 3.6p. Cash stood at £11.0m at 30 June 2026, down from £12.4m at the end of 2025. The reduction reflects, in part, a £3m share buyback programme, of which £2.1m was repurchased during the period. The programme was completed in July 2026, according to a company announcement dated 27 July.

Buybacks reduce the number of shares in issue, which can lift per-share measures such as earnings, but they also use cash that could otherwise fund acquisitions or Capital spending. Investors typically weigh that trade-off alongside the dividend.

Sector and index context

Animal health and nutrition businesses sit within a defensive part of the market, since demand for protein and for healthy livestock is relatively steady. Even so, they are exposed to currency swings, raw material costs and regional trade disruption. Anpario's international footprint is a strength in diversifying risk, but it also means that geopolitical shocks can show up quickly in reported sales.

AIM constituents tend to be smaller and less liquid than main-market peers, so share prices can react sharply to trading statements. No share price or index weighting figure has been verified for this article, and none is given.

Risks the company has flagged

The central near-term risk is the one management itself identified: the Iran conflict is hurting sales across the Asia region and has softened the start to the second half. The board expects these pressures to persist for the remainder of the year. Management nonetheless said it remains confident, pointing to Business development, its order pipeline and geographic diversity.

Other general risks for feed additive producers include regulatory change on additives and antibiotics, customer concentration, input cost Inflation and disease outbreaks that disrupt herds and flocks.

What to watch next

The next scheduled milestone is likely to be a trading statement or full-year results covering 2026, although no date was found in the sources reviewed. Readers may wish to look for updates on Asian demand, Margin progress after the Bio-Vet rebrand, and any further capital returns after the completed buyback.